EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet AMD

EyePoint Pharmaceuticals announced the completion of enrollment for its Phase 3 LUCIA trial evaluating DURAVYU™ for wet age-related macular degenerati...
Home/KnloSights/Clinical Trial Updates/EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet AMD